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ABSTRACT
EndoNet is a new database that provides information
10 about the components of endocrine networks and
their relations. It focuses on the endocrine cell-
to-cell communication and enables the analysis of
intercellular regulatory pathways in humans. In the
EndoNet data model, two classes of components
15 span a bipartite directed graph. One class represents
the hormones (in the broadest sense) secreted by
defined donor cells. The other class consists of the
acceptor or target cells expressing the correspond-
ing hormone receptors. The identity and anatomical
20 environment of cell types, tissues and organs is
defined through references to the CYTOMER  ontol-
ogy. With the EndoNet user interface, it is possible to
query the database for hormones, receptors or
tissues and to combine several items from different
25 search rounds in one complex result set, from which
a network can be reconstructed and visualized. For
each entity, a detailed characteristics page is avail-
able. Some well-established endocrine pathways
are offered as showcases in the form of predefined
30 result sets. These sets can beused as astarting point
for a more complex query or for obtaining a quick
overview. The EndoNet database is accessible at
http://endonet.bioinf.med.uni-goettingen.de/.
INTRODUCTION
35 Theoretical analyses in the post-sequencing era, in particular
in the context of systems biology approaches, increasingly
investigate the properties of all kinds of pathways and net-
works such as metabolic and signaling pathways. It is com-
monly accepted that we need formal descriptions of these
40 networks to make systematic use of the overwhelming body
of facts gathered over decades of laboratory work both in
narrow or global scale.
Corresponding databases have been created and are avail-
able now for metabolic networks (KEGG) (1,2), protein
45 interaction networks (BIND and DIP) (3,4) and signaling path-
ways (CSNDB, Patika and TRANSPATH ) (5–8), just to
name a few. So far, however, their main focus is on intracel-
lular processes. Intercellular signaling is addressed only inso-
far as usually the pathways modeled start with extracellular
50 ligands, and as there exist catalogs and databases about
secreted proteins, or the ‘secretome’, of certain systems
(9–12).
This shortcoming is part of the more comprehensive prob-
lem, thegenotype–phenotypegap: fromacertain genotype,we
55 are able to infer a ‘molecular phenotype’, but for correlating
it with a more complex phenotype such as a biological
process, or even a certain disease and its clinical appearance,
we still depend largely on the mere description of an observed
correlation. There is no way to infer such a phenotype through
60 all the different layers of increasing complexity between
genomic DNA sequences and the physiological function of
whole organs and their interplay within an organism.
There may be principal barriers preventing such an infer-
ence across different complexity levels, but even to explore
65 these limits, we have to make attempts to bridge the genotype–
phenotype gap. We have to do the next step towards modeling
intercellular networks that are inextricably linked to the physi-
ology of multicellular organisms (13). Being one of the most
complex constructs in the body, the endocrine system com-
70 prises numerous cells and tissues that secrete hormones which
pass through the body, activate speciﬁc receptors of target
cells and initiate there multiple intracellular signaling
pathways.
Here, we present a new database, EndoNet, which provides
75 information about the components of endocrine networks
and their relations, and enables the analysis of intercellular
regulatory pathways in humans. The EndoNet database is
accessible at http://endonet.bioinf.med.uni-goettingen.de/.
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The biological schema of endocrine actions
Development and function of different organs as well as the
response of a whole multicellular organism to its environment
5 is coordinated through a complex communication system
between specialized cells that are part of its organs. This
communication is mostly mediated by hormones. In a broader
sense, this functional class of biomolecules also comprises
growth factors, cytokines, chemokines and other signal trans-
10 mitters. This generic view is supported, for instance, by the
deﬁnition given for ‘hormone activity’ by Gene Ontology
(GO) (14): ‘Any substance formed in very small amounts
in one specialized organ or group of cells and carried (some-
times in the bloodstream) to another organ or group of cells,
15 in the same organism, upon which it has a speciﬁc regulatory
action’. This deﬁnition is also broad enough to include
modes of hormonal actions as diverse as endocrine, paracrine
and autocrine effects. Accordingly, with the term ‘hormone’
one might refer to any extracellular substance that induces
20 speciﬁc responses in target cell and helps to coordinate
growth, differentiation, gene expression and metabolic
activities of various cells, tissues and organs in multicellular
organisms (15).
Hormones can be classiﬁed based on their chemical nature,
25 solubility, the distance over which the signal acts and so on
(15,16). From the viewpoint of genome–phenotype relations,
it is reasonable to distinguish between polypeptide, thus,
genome-encoded hormones, on one hand, and those low-
molecular weight hormones such as steroids, with only the
30 machinery of their synthesis being genome-encoded, on the
other hand. Another classiﬁcation of hormones, which seems
to be overlapping with the previous one refers to the intracel-
lular location of their receptors and, thus, how the subsequent
signal is further transduced: membrane-bound receptors usu-
35 ally trigger more or less complex signaling cascades towards
the nucleus, whereas nuclear receptors, mainly bound by
low-molecular weight hormones, have a very short signaling
pathway downstream since they act as transcription factors
themselves (15,16).
40 In intercellular communication, we can basically differen-
tiate between two kinds of cells: donor cells which synthesize
and secrete a hormone, and acceptor cells which express a
hormone receptor (Figure 1a). Donor cells become active
under the inﬂuence of an external, mostly environmental,
45 stimulus. In the acceptor cell, binding of the hormone to a
receptor triggers an intracellular signal transduction cascade
with different kinds of end nodes and effects: transcription
factors affecting the gene expression program of the acceptor
cell, metabolic enzymes controlling the cell’s metabolism,
50 structural components which deﬁne the acceptor’s morpho-
logical features, or components of the secretory apparatus
regulating the release of other extracellular molecules. If syn-
thesis and secretion of another hormone is among the effects
exerted by receptor activation, the acceptor is turned into a
55 donor cell, thus becoming an internal node of the organism’s
endocrine network. Acceptor cells which do not become pro-
ducers of another hormone are called ‘terminal target cells’ of
the endocrine network, but ﬁnally constitute the overall
physiological effect of the respective hormonal pathway, or
60 simply the phenotype (Figure 1a).
The EndoNet data model
In the EndoNet data model, two classes of entities—hormones
(in the broadest sense) and their acceptor or target cells
expressing the corresponding receptors—span a bipartite
65 directed graph. Since one and the same hormone may be
secreted by multiple cell types (donor cells), each such secre-
tion event is represented by a hormone node on its own. Simi-
larly, each cell type known to express a hormone receptor
(acceptor cell) leads to an individual node. The graph’s edges
70 represent hormone transport and binding to a receptor (inter-
cellular edges), on one hand, and triggering or inhibition of
hormone secretion by a receptor activated by hormone binding
(intracellular edges), on the other hand. Optionally, an edge
representing the transport of a hormone can be subdivided by
75 introducing the transport medium (usually blood) as an addi-
tional, intermediary node.
Thus, in the conceptual schema of the EndoNet database
(Figure1b),the linksbetween cells/organs andhormonedeﬁne
donor cells (‘D’), those between cells/organs and receptors
80 acceptor cells (‘A’). If an acceptor cell synthesizes another
hormone in response to an incoming signal, it becomes an
internal node in the emerging hormonal network.
In EndoNet, the pathway between a hormone receptor
expressed in an acceptor cell and a hormone synthesized in
85 the same cell (intracellular edge) is handled as a black box. In
case of genome-encoded peptide hormones, cross-references
to entries in the TRANSPATH  database, which describe the
signaling cascade starting from the hormone’s receptor and
ending at the hormone’s gene, are provided, if available. Data-
90 sets on non-peptide hormones will in future be enriched by a
speciﬁc metabolic add-on which will include references to the
databases KEGG (1) and BRENDA (17), allowing for further
characterization of the steps performed during the hormone’s
synthesis and the regulation of both activity and expression of
95 the enzymes involved.
By now, the EndoNet structure already allows for including
descriptions of the physiological effects induced by hormone
binding (see below, Future Developments).
The contents of EndoNet
100 In the present version of EndoNet, and as a ﬁrst approach, we
consider the endocrine (hormonal) network of the human
body. For each molecule (hormone or receptor), a primary
name and synonyms are given. In case of peptide hormones,
the sequence of the processed polypeptide, rather than that of
105 the protein precursor, is speciﬁed. For a multimeric protein
hormone, the subunit composition as well as the sequences
of all subunits are stored; the same holds true for hormone
receptors.
Additionally, all peptide hormone and receptor datasets
110 have links to HumanPSD  (18) and to the Swiss-Prot data-
base, The structures of non-peptide hormones can be accessed
through the corresponding hyperlinks to the KEGG COM-
POUND section. Finally, all molecules may have links to
the TRANSPATH  database.
115 As described, EndoNet utilizes data about the tissues from
which hormones are secreted and in which receptors are
expressed to deﬁne donor and acceptor cells, respectively. The
identity and anatomical environment of cell types, tissues and
organs is deﬁned through references to the CYTOMER 
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are ubiquitously expressed, just the root term ‘human body’ is
linked.
Data on whether a hormone’s synthesis is triggered or inhib-
5 ited by another hormone through its respective receptor in
a particular cell was obtained by manual selection from text-
books [e.g. (16), http://endotext.com/], monographies (21),
original literature, the EST library information and the linked
databases (TRANSPATH , HumanPSD
TM and Swiss-Prot).
10 The contents of EndoNet are summarized in Table 1.
Web interface, queries and visualization
EndoNet can be accessed through the WWW via a JSP-based
web interface. Hormones, receptors and tissues can be queried
for their names, and detailed information on all identiﬁed
15 components is available through individual characteristics
pages. Each hormone’s individual entry page displays its
source and target tissues (donor and acceptor cells) as well
as its receptors, along with some molecular data. Similarly,
each receptor entry exhibits the tissues in which the receptor is
20 expressed, and the hormones it interacts with. Finally, each
tissue entry lists the hormone receptors that are found in, as
well as the hormones that are synthesized and secreted by the
tissue. It is also indicated whether the corresponding tissue
exertsgender-speciﬁc properties; additional information based
25 on the CYTOMER  ontology is available through the corre-
sponding link on the tissue detail page.
Instead of searching for a name of a hormone, one can also
browse the hierarchical hormone classiﬁcation featured by
EndoNet (available at the ‘Search’ page).
Figure1.StructureofthehormonalnetworkmodeledinEndoNet.(a)SchematicstructureoftherelationalEndoNetdatabase.(b)TherhombsdesignatedDandAare
the linking tables between a tissue (cell, organ) and a hormone or a receptor, respectively, and represent the corresponding hormone donor or acceptor cell.
D542 Nucleic Acids Research, 2006, Vol. 34, Database issueEach query result can be used as starting point for an
extended query. Different items of interest can be selected
and added to a common result set. Since several search results
can be combined, it is possible to create sets with multiple
5 search parameters.
At any step of this incremental retrieval process, the sets of
hormones, receptors and tissues obtained so far can be used as
starting points for reconstructing a network by a depth-ﬁrst
graph traversal algorithm. The maximum number of steps can
10 be selected separately forthe upstream anddownstream part of
the reconstruction process. Subsequently, the graph will be
displayed using a Graphviz-based visualization method [(22),
http://www.graphviz.org]. In the resulting image, hormones
and receptors are represented as nodes grouped together
15 into subgraphs representing the tissues (cells/organs) they
are secreted from or expressed in, respectively (Figure 2).
Autocrine loops (donor and acceptor cell being identical)
are treated specially for visualization. On demand, the
hormones’ transport media can be included in the visualiza-
20 tion of intercellular edges, enabling the user to choose
between different complexities of output. Intracellular edges,
which connect a receptor to a hormone, represent the inﬂuence
of a receptor’s activation on the secretion of a hormone from
the same cell and are displayed differently, depending on
25 whether this inﬂuence is triggering or inhibitory in nature.
Table 1. Contents of EndoNet
Components Number of entries
(17/10/2005)
Molecules
Hormones 109
Receptors 117
Cellular sources
Cells/tissues 112
Relations
Hormone–receptor 149
Donor cell–hormone 184
Receptor–acceptor cell 292
Information sources
References 264
Figure 2. Screenshotwithanexampleofnetworkvisualization,onlypartiallydrawnforclarity.Theblueovalsrepresenthormonesandthegreenhexagonshormone
receptors. The same symbols in red indicate the queried entities. The blue, green and red edges display hormone binding to a receptor, stimulation of synthesis/
secretion of another hormone or inhibition of the latter effect, respectively. The brown boxes represent a defined tissue (organ, cell).
Nucleic Acids Research, 2006, Vol. 34, Database issue D543The graph is displayed as a clickable image map, linking
each entity to its detailed characteristics page, thus making the
database entries accessible from the graphical overview of a
network, too. The graph is available in two different formats:
5 PNG and SVG. While virtually every browser supports PNG
(a ‘pixel’ or ‘bitmap’ format), only a few of them provide a
zoom functionality for bitmap pictures. Scalable vector graph-
ics, (SVG) provides more functionality (including perfect
image quality throughout all zoom factors), but until now
10 most browsers do not support SVG natively and require an
SVG plugin (www.adobe.com/svg/viewer/install/main.html)
for displaying this vector-based format.
Some well-established endocrine pathways are offered as
showcases in the form of predeﬁned result sets. For instance,
15 sets representing the hypothalamic–hypophyseal axis with a
focus on either thyroid hormones, adrenal hormones, growth
hormones or prolactin are provided. These predeﬁned sets can
be used for obtaining a quick overview or as starting points for
more complex queries.
20 FUTURE DEVELOPMENTS
Among the important improvements of EndoNet which we are
currentlyworkingonisthepossibilitytorepresentintercellular
communication at different levels of the hierarchical organ-
izationoforgans,tissuesandcellsintheorganism,aswellasto
25 distinguish between such communications in male and female
organisms. These options will be introduced by a tighter inte-
gration with the CYTOMER-based ontology (19,20).
The next step will be to expand the contents of EndoNet
towards the details of the processes occurring in the transport
30 medium, usually the blood. Since not all hormones are trans-
portedasfreemoleculesandsomehydrophobichormones(e.g.
steroids and thyroids) need to be bound to speciﬁc carrier
proteins,properdescriptionofsuchtransportersandtheirinter-
action with the corresponding hormones will be required. It is
35 plannedtoinvolve quantitativedata about the regular orpatho-
logical levels of the hormones, the overall kinetics of each
hormone in the blood (monotonous decay, oscillating con-
centrations, increase in response to certain stimuli, etc.), its
turnover and metabolic products, etc. That will allow utiliza-
40 tionofEndoNetcontentsfordiagnosticpurposes.Infuture, the
EndoNet data model will be extended in order to incorporate
externalstimuli(e.g.light)andphysiologicalstates(stress,age,
etc.) in a formalized manner, allowing to determine whether or
not and in which quantity a hormone will be secreted under the
45 given circumstances. EndoNet will then link the physiological
effects of hormones with the intracellular molecular processes
leading to its synthesis and secretion in the donor cells, and to
the effects on its acceptor cells. At many places of these intra-
cellular and intercellular networks, genetically determined
50 aberrations may cause speciﬁc, sometimes pathological phe-
notypes. Thus, EndoNet will enable to bridge the gap between
known genotypes and their molecular and clinical phenotypes
in this area of medical research and its applications.
DISCUSSION
55 At its present state, EndoNet provides a high coverage of
molecules that are conventionally considered as hormones
as well as other molecules that are involved in intercellular
communication, such as growth factors, lymphokines and che-
mokines and their known receptors. The aim of the database is
60 to provide a useful resource for studying the principal features
of hormonal networks in a comprehensive way, as it was done
more exemplarily in the past for these kinds of networks (23),
but was done globally for many other intracellular network
types, such as metabolic, protein interaction and transcription
65 networks [reviewed in (24,25)]. EndoNet database certainly is
not yet complete but will grow rapidly.
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